Skip to main content
Premium Trial:

Request an Annual Quote

South Korea's NIH Expands Human Disease Study with Affy Microarray Buy

NEW YORK (GenomeWeb News) – South Korea’s National Institute of Health and Center for Disease Control and Prevention plans to use Affymetrix’s Genome-Wide Human SNP Array 6.0 as it expands the Korean Association Resource project (KARE), which is focused on discovering genes that are associated with lifestyle-related complex disorders, Affy said today.
The KARE project initially bought Affy’s SNP Array 5.0 in July 2007, in order to generate genotypes from 10,000 human samples. The expanded program aims to analyze 13,000 additional samples and to validate earlier findings, the company said.
The Affy microarrays will be run by DNA Link, which is an Affy-certified service provider in Korea, and they will be supplied by SeouLin Bioscience, which also will provide technical support for the KARE project.
“Once we have validated our initial results with the SNP Array 6.0, we can use these samples as a common control set to help inspire additional research projects,” said Jong-Young Lee, who is chief of the Korean NIH’s Division of Structural and Functional Genomics.
Financial terms of the agreement were not released.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.